Genetic Analysis of SCN5A Gene in Patients of Long QT Syndrome
Abstract
Background: Finding out the cause of death is the main concern in forensic casework, particularly in sudden unexplained death cases. Long QT syndrome is a form of life debilitating cardiac arrhythmia. Among LQT genes, LQT3 is suggested to be more lethal and patients are at high probability of sudden death as compared to LQT1 and LQT2 patient.
Methods: Samples of long QT patients were collected and the coding regions of all exons of the SCN5A, voltage- gated Na+ channel gene were screened by sequencing for the potential mutations as the causative agent of long QT syndrome.
Results: After data analysis, 3 genetic variations have been found, amongst them are 2 heterozygous mutations that were reported previously in other ethnicity G87A-A29A found in exon 2, G1673A-H558R in exon 12 and one novel mutation that has not been reported so far, G>A 1238-G412G resulting in a transition mutation and change in amino acid GGG- Glycine to GAG- glutamic acid at position 412 in exon 9. While in other exons, no significant mutation was found.
Conclusion: As some of the exons showed mutation and the sample size was small, however, further functional analysis of the gene is needed with large number of samples for the confirmation of results.
Keywords: Long QT Syndrome; SCN5A gene; Genetic variations; Sudden death
Full Text:
PDFReferences
Rodríguez-Calvo MS, Brion M, Allegue C, Concheiro L, Carracedo A. Molecular genetics of sudden cardiac death. Forensic science international, (2008); 182(1-3): 1-12.
Stattin E-L, Westin IM, Cederquist K, Jonasson J, Jonsson B-A, et al. Genetic screening in sudden cardiac death in the young can save future lives. International journal of legal medicine, (2016); 130(1): 59-66.
Zipes DP, Wellens HJ. Sudden cardiac death. Circulation, (1998); 98(21): 2334-2351.
Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. European heart journal, (2013); 34(40): 3109-3116.
Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation, (2001); 103(1): 89-95.
Virmani R, Burke AP, Farb A. Sudden cardiac death. Cardiovascular pathology, (2001); 10(5): 211-218.
Liu C, Zhao Q, Su T, Tang S, Lv G, et al. Postmortem molecular analysis of KCNQ1, KCNH2, KCNE1 and KCNE2 genes in sudden unexplained nocturnal death syndrome in the Chinese Han population. Forensic science international, (2013); 231(1-3): 82-87.
Kauferstein S, Kiehne N, Jenewein T, Biel S, Kopp M, et al. Genetic analysis of sudden unexplained death: a multidisciplinary approach. Forensic science international, (2013); 229(1): 122-127.
Shinnawi R, Gepstein L. iPCS cell modeling of inherited cardiac arrhythmias. Current treatment options in cardiovascular medicine, (2014); 16(9): 1-18.
Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm, (2004); 1(5): 600-607.
Park HS, Kim YN, Lee YS, Jung BC, Lee SH, et al. Genetic analysis of SCN5A in Korean patients associated with atrioventricular conduction block. Genomics & informatics, (2012); 10(2): 110-116.
Grant AO. Molecular biology of sodium channels and their role in cardiac arrhythmias. The American journal of medicine, (2001); 110(4): 296-305.
Vatta M, Dumaine R, Varghese G, Richard TA, Shimizu W, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Human molecular genetics, (2002); 11(3): 337-345.
Schwartz PJ. The congenital long QT syndromes from genotype to phenotype: clinical implications. Journal of internal medicine, (2006); 259(1): 39-47.
Green M, Sambrook J, Sambrook J. Molecular cloning: a laboratory manual 4 edition Cold Spring Harbor Laboratory Press. New York, (2012).
Koo S, Teo W, Ching C, Chan S, Lee EJ. Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family. ANNALS-ACADEMY OF MEDICINE SINGAPORE, (2007); 36(6): 394.
Veltmann C, Barajas‐Martinez H, Wolpert C, Borggrefe M, Schimpf R, et al. Further insights in the most common SCN5A mutation causing overlapping phenotype of long QT syndrome, Brugada syndrome, and conduction defect. Journal of the American Heart Association, (2016); 5(7): e003379.
Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, et al. Spectrum of mutations in long-QT syndrome genes. Circulation, (2000); 102(10): 1178-1185.
Iwasa H, Itoh T, Nagai R, Nakamura Y, Tanaka T. Twenty single nucleotide polymorphisms (SNPs) and their allelic frequencies in four genes that are responsible for familial long QT syndrome in the Japanese population. Journal of human genetics, (2000); 45(3): 182-183.
Keller DI, Acharfi S, Delacrétaz E, Benammar N, Rotter M, et al. A novel mutation in SCN5A, delQKP 1507–1509, causing long QT syndrome:: Role of Q1507 residue in sodium channel inactivation. Journal of molecular and cellular cardiology, (2003); 35(12): 1513-1521.
Wang Q. Author’s reply: link of SCN5A SNP R1193Q to long QT syndrome. Journal of medical genetics, (2005); 42(2): e8-e8.
Gellens ME, George AL, Chen L, Chahine M, Horn R, et al. Primary structure and functional expression of the human cardiactetrodotoxin-insensitive voltage-dependent sodium channel. Proceedings of the National Academy of Sciences, (1992); 89(2): 554-558.
Viswanathan PC, Benson DW, Balser JR. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. The Journal of clinical investigation, (2003); 111(3): 341-346.
Boehringer T, Bugert P, Borggrefe M, Elmas E. SCN5A mutations and polymorphisms in patients with ventricular fibrillation during acute myocardial infarction. Molecular medicine reports, (2014); 10(4): 2039-2044.
DOI: http://dx.doi.org/10.62940/als.v7i1.829
Refbacks
- There are currently no refbacks.